ABT-737 and/or folate reverse the PDGF-induced alterations in the mitochondrial apoptotic pathway in low-grade glioma patients

Clinical Epigenetics

Volumn 2, Issue 2, 2011, Pages 369-381

  Debien, Emilie ^a,b   Hervouet, Eric ^a,b   Gautier, Fabien ^a,b,c   Juin, Philippe ^a,b   Vallette, Francois M ^b   Cartron, Pierre Francois ^b  

^a Team 12   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c U892 Equipe Survie Cellulaire et Échappement Tumoral dans les Cancers du Sein ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; BH3 PROTEIN; BIM PROTEIN; ETOPOSIDE; FOLIC ACID; PLATELET DERIVED GROWTH FACTOR; PROTEIN BAD; PUMA PROTEIN; VITAMIN B GROUP;

APOPTOSIS; ARTICLE; BCL W GENE; BCL XL GENE; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA METHYLATION; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GLIOMA; HUMAN; HUMAN CELL; NUCLEAR REPROGRAMMING; PHENOTYPE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR GENE;

EID: 84856263516     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1007/s13148-011-0035-5     Document Type: Article

References (47)

1. Bougras G, Cartron P, Gautier F, Martin S, LeCabellec M et al (2004) Opposite role of Bax and BCL-2 in the anti-tumoral responses of the immune system. BMC Cancer 4(1):54
2. Cartron PF, Oliver L, Martin S, Moreau C, LeCabellec MT et al (2002) The expression of a new variant of the pro-apoptotic molecule Bax, Baxpsi, is correlated with an increased survival of glioblastoma multiforme patients. Hum Mol Genet 11(6):675-687 (Pubitemid 34285139)
3. Cartron PF, Juin P, Oliver L, Martin S, Meflah K et al (2003) Nonredundant role of Bax and Bak in Bid-mediated apoptosis. Mol Cell Biol 23(13):4701-4712 (Pubitemid 36734757)
4. Cartron P, Gallenne T, Bougras G, Gautier F, Manero F et al (2004) The first alpha helix of Bax plays a necessary role in its ligandinduced activation by the BH3-only proteins Bid and PUMA. Mol Cell 16(5):807-818 (Pubitemid 39586538)
5. Certo M, Del Gaizo MV, Nishino M, Wei G, Korsmeyer S et al (2006) Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 9 (5):351-365 (Pubitemid 43668734)
6. Cole B, Baron J, Sandler R, Haile R, Ahnen D et al (2007) Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 297(21):2351-2359 (Pubitemid 46883748)
7. Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN et al (2001) PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 15 (15):1913-1925 (Pubitemid 32738621)
8. Del Bufalo D, Trisciuoglio D, Biroccio A, Marcocci L, Buglioni S et al (2001) Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity. J Cell Biochem 83(3):473-483 (Pubitemid 33027491)
9. Enyedy I, Ling Y, Nacro K, Tomita Y, Wu X et al (2001) Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening. J Med Chem 44(25):4313-4324 (Pubitemid 33131658)
10. Evan G, Vousden K (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411(6835):342-348 (Pubitemid 32467043)
11. Gallenne T, Gautier F, Oliver L, Hervouet E, Noël B et al (2009) Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members. J Cell Biol 185 (2):279-290
12. Hanahan D, Weinberg R (2000) The hallmarks of cancer. Cell 100 (1):57-70 (Pubitemid 30046295)
13. Harada H, Quearry B, Ruiz-Vela A, Korsmeyer S (2003) Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity. Proc Natl Acad Sci USA 101(43):15313-15317 (Pubitemid 39441538)
14. Hervouet E, Debien E, Charbord J, Menanteau J, Vallette FM et al (2009) Folate supplementation: a tool to limit the aggressiveness of gliomas via the re-methylation of DNA repeat element and genes governing apoptosis and proliferation. Clin Cancer Res 15 (10):3519-3529
15. Hsu Y, Youle R (1997) Nonionic detergents induce dimerization among members of the Bcl-2 family. J Biol Chem 272 (21):13829-13834 (Pubitemid 27224822)
16. Kim H, Rafiuddin-Shah M, Tu H, Jeffers J, Zambetti G et al (2006) Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 8(12):1348-1358 (Pubitemid 44835109)
17. Kojima K, Konopleva M, Samudio I, Schober W, Bornmann W et al (2006) Concomitant inhibition of MDM2 and Bcl-2 protein function synergistically induce mitochondrial apoptosis in AML. Cell Cycle 5(23):2778-2786 (Pubitemid 44901740)
18. Konopleva M, Contractor R, Tsao T, Samudio I, Ruvolo P et al (2006) Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell 10 (5):375-388 (Pubitemid 44693472)
19. Kulms D, Schwarz T (2000) Molecular mechanisms of UV-induced apoptosis. Photodermatol Photoimmunol Photomed 16(5):195-201
20. Kutzki O, Park H, Ernst J, Orner B, Yin H et al (2002) Development of a potent Bcl-x(L) antagonist based on alpha-helix mimicry. J Am Chem Soc 124(40):11838-11839
21. Lemaire M, Chabot G, Raynal N, Momparler L, Hurtubise A et al (2008) Importance of dose-schedule of 5-aza-2′-deoxycytidine for epigenetic therapy of cancer. BMC Cancer 8:128
22. Leone M, Zhai D, Sareth S, Kitada S, Reed J et al (2003) Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. Cancer Res 63(23):8118-8121 (Pubitemid 37549456)
23. Lessene G, Czabotar P, Colman P (2008) BCL-2 family antagonists for cancer therapy. Nat Rev Drug Discov 7(12):989-1000
24. Lindzon G, Medline A, Sohn K, Depeint F, Croxford R et al (2009) Effect of folic acid supplementation on the progression of colorectal aberrant crypt foci. Carcinogenesis 30(9):1536-1543
25. Lowe S, Lin A (2000) Apoptosis in cancer. Carcinogenesis 21(3):485-495 (Pubitemid 30137934)
26. Luciano F, Jacquel A, Colosetti P, Herrant M, Cagnol S et al (2003) Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function. Oncogene 22(43):6785-6793 (Pubitemid 37372218)
27. Manero F, Gautier F, Gallenne T, Cauquil N, Grée D et al (2006) The small organic compound HA14-1 prevents Bcl-2 interaction with Bax to sensitize malignant glioma cells to induction of cell death. Cancer Res 66(5):2757-2764
28. Martin S, Toquet C, Oliver L, Cartron P, Perrin P et al (2001) Expression of bcl-2, bax and bcl-xl in human gliomas: a reappraisal. J Neurooncol 52(2):129-139 (Pubitemid 32691175)
29. Mason K, Carpinelli M, Fletcher J, Collinge J, Hilton A et al (2007) Programmed anuclear cell death delimits platelet life span. Cell 128(6):1035-1036
30. Nagane M, Levitzki A, Gazit A, Cavenee W, Huang H (1998) Drug resistance of human glioblastoma cells conferred by a tumorspecific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases. Proc Natl Acad Sci USA 95(10):5724-5729
31. Nakamura M, Ishida E, Shimada K, Nakase H, Sakaki T et al (2005) Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas. Acta Neuropathol 110(4):402-410 (Pubitemid 41672185)
32. Oliver L, Mahé B, Gréé R, Vallette F, Juin P (2007) HA14-1, a small molecule inhibitor of Bcl-2, bypasses chemoresistance in leukaemia cells. Leuk Res 31(6):859-863 (Pubitemid 46855902)
33. Oltersdorf T, Elmore S, Shoemaker A, Armstrong R, Augeri D et al (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435(7042):677-681 (Pubitemid 40825512)
34. Pellecchia M, Reed J (2004) Inhibition of anti-apoptotic Bcl-2 family proteins by natural polyphenols: new avenues for cancer chemoprevention and chemotherapy. Curr Pharm Des 10(12):1387-1398 (Pubitemid 38559755)
35. Reed J (2003) Apoptosis-targeted therapies for cancer. Cancer Cell 3 (1):17-22 (Pubitemid 37443888)
36. Reed J, Pellecchia M (2005) Apoptosis-based therapies for hematologic malignancies. Blood 106(2):408-418 (Pubitemid 40981231)
37. Shin S, Sung B, Cho Y, Kim H, Ha N et al (2001) An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40(4):1117-1123 (Pubitemid 32108606)
38. Stidley C, Picchi M, Leng S, Willink R, Crowell R et al (2010) Multivitamins, folate, and green vegetables protect against gene promoter methylation in the aerodigestive tract of smokers. Cancer Res 70(2):568-574
39. Stolzenberg-Solomon R, Chang S, Leitzmann M, Johnson K, Johnson C et al (2006) Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr 83(4):895-904 (Pubitemid 44713156)
40. Tran N, McDonoughW, Savitch B, Sawyer T, Winkles J et al (2005) The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-Wexpression. J Biol Chem 280(5):3483-3492 (Pubitemid 40223813)
41. van Delft M, Wei A, Mason K, Vandenberg C, Chen L et al (2006) The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 10(5):389-399 (Pubitemid 44711953)
42. Van Guelpen B, Hultdin J, Johansson I, Hallmans G, Stenling R et al (2006) Low folate levels may protect against colorectal cancer. Gut 55(10):1461-1466 (Pubitemid 44476792)
43. Wang J, Liu D, Zhang Z, Shan S, Han X et al (2000) Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc Natl Acad Sci USA 97 (13):7124-7129 (Pubitemid 30431428)
44. Weiler M, Bähr O, Hohlweg U, Naumann U, Rieger J et al (2006) BCL-xL: time-dependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells. Cell Death Differ 13(7):1156-1169 (Pubitemid 43905596)
45. Weller M, Malipiero U, Aguzz IA, Reed J, Fontana A (1995) Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J Clin Invest 95(6):2633-2643
46. Zhang H, Nimmer P, Tahir S, Chen J, Fryer R et al (2007a) Bcl-2 family proteins are essential for platelet survival. Cell Death Differ 14(4):703-715
47. Zhang L, Ming L, Yu J (2007b) BH3mimetics to improve cancer therapy; mechanisms and examples. Drug Resist Updat 10(6):207-217 (Pubitemid 351163146)